海利生物(603718.SH)子公司两款体外诊断试剂获医疗器械注册证

智通财经APP讯，海利生物(603718.SH)公告，公司全资子公司上海捷门生物技术有限公司(“捷门生物”)相关产品于近日收到上海市药品监督管理局颁发的《医疗器械注册证》(体外诊断试剂)。据悉，免疫球蛋白G测定试剂盒(胶乳增强免疫比浊法)用于体外测定人尿液样本中免疫球蛋白G的含量;尿微量白蛋白测定试剂盒(胶乳增强免疫比浊法)用于体外测定人尿液样本中尿微量白蛋白的含量。

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.